CureBay Biopharmaceutical

CureBay Biopharma is a Suzhou-based biotechnology company focused on the development of mRNA-based vaccines and therapeutics. Founded by experts in drug delivery and nucleic acid chemistry, the company utilizes a proprietary lipid nanoparticle (LNP) platform to optimize the stability and delivery of mRNA payloads. Its primary research focus includes infectious disease prevention and innovative oncology treatments. CureBay is currently advancing its lead mRNA vaccine candidates through clinical trials while expanding its pipeline into personalized cancer vaccines and protein replacement therapies. The company aims to build an integrated platform covering the entire mRNA drug development lifecycle, from sequence design to large-scale GMP manufacturing.